Endovia Health Sciences (EDVA) Total Non-Current Liabilities (2018 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.50 Bn | 133.65 Bn | 2.84 Bn | 5.92 Bn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | 7.74 Bn |
| 3 | Argenx Se | 65.05 Bn | 59.86 Bn | 1.37 Bn | 40.00 Mn |
| 4 | Moderna | 57.11 Bn | 51.98 Bn | 52.00 Mn | 3.92 Bn |
| 5 | Revolution Medicines | 44.71 Bn | 44.71 Bn | - | 1.53 Bn |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn | 1.88 Bn |
| 7 | Alnylam Pharmaceuticals | 35.36 Bn | 32.05 Bn | 992.69 Mn | 4.20 Bn |
| 8 | Royalty Pharma | 28.16 Bn | 27.32 Bn | - | 9.32 Bn |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 1.17 Bn |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 857.00 |
| Dec 31, 2025 | 6,394.00 |
| Sep 30, 2025 | 69,815.00 |
| Jun 30, 2025 | 72,564.00 |
| Mar 31, 2025 | 2.12 Mn |
| Dec 31, 2024 | 2.02 Mn |
| Sep 30, 2024 | 1.41 Mn |
| Jun 30, 2024 | 1.59 Mn |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 753,784.00 |
| Sep 30, 2023 | 772,114.00 |
| Jun 30, 2023 | 601,616.00 |
| Mar 31, 2023 | 2.86 Mn |
| Dec 31, 2022 | 3.02 Mn |
| Sep 30, 2022 | 785,875.00 |
| Jun 30, 2022 | 951,518.00 |
| Mar 31, 2022 | 668,693.00 |
| Dec 31, 2021 | 1.03 Mn |
| Sep 30, 2021 | 3.93 Mn |
| Jun 30, 2021 | 4.07 Mn |